阿根廷婴儿和青少年采用4CMenB与MenACWY-CRM197不同疫苗接种策略对脑膜炎球菌疾病的影响
阿根廷2017年将MenACWY纳入国家免疫规划(cNIP)用于婴儿和青少年,但B群自2015年起在儿童中占优势。研究用已发表的动态传播模型适配阿根廷,比较6种含4CMenB和/或MenACWY的接种策略与cNIP。含青少年MenACWY联合婴儿4CMenB的策略对提升IMD预防效果最大,25年后较cNIP高至23%;含4CMenB策略在引入后前5年使B群IMD下降39%;含青少年MenACWY策略30年后ACWY群接近消除。
要点
- 含青少年MenACWY联合婴儿4CMenB的策略25年后IMD预防效果较cNIP高至23%。
- 含4CMenB策略在引入后前5年使0-4岁儿童B群IMD下降39%。
- 含青少年MenACWY策略30年后ACWY群IMD接近消除,全年龄受益于群体保护。
核心结论
- 在阿根廷,常规婴儿接种4CMenB(加入完整cNIP或替代婴儿MenACWY)可进一步减少IMD病例、后遗症和死亡。
- 维持青少年MenACWY规划及其群体免疫效益,可在30年内使ACWY群IMD接近消除。
研究设计与样本
- 采用已发表的动态传播模型并适配阿根廷,评估6种疫苗接种策略与cNIP比较。
- 6种策略为:婴儿单独4CMenB(1)、婴儿4CMenB联合青少年MenACWY(2)、青少年单独MenACWY(3)、婴儿4CMenB和MenACWY(4)、婴儿单独MenACWY(5)、婴儿4CMenB和MenACWY联合青少年MenACWY(6)。
主要发现
- 含青少年MenACWY联合婴儿4CMenB(或4CMenB加MenACWY)的策略对提升IMD预防效果最大,25年后较cNIP高至23%。
- 含4CMenB策略(1、2、4、6)使B群IMD下降最大,在引入后前5年下降39%,影响见于0-4岁儿童。
- 含青少年MenACWY策略(cNIP、2、3、6)使ACWY群IMD下降最大,30年后接近消除,因群体保护影响见于所有年龄。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Invasive meningococcal disease (IMD) is a life-threatening disease, primarily affecting infants and children. Argentina introduced routine meningococcal vaccination in infants and adolescents in 2017, with MenACWY vaccination targeting serogroups A, C, W, and Y (current National Immunization Program [cNIP]). Serogroup B, more prevalent since 2015, became predominant in children. The dynamic trends of IMD epidemiology and availability of a four-component meningococcal B vaccine (4CMenB) call for a reassessment of the best schedule to optimize IMD prevention. The objective was to model the public health impact of routine 4CMenB and/or MenACWY in infants and adolescents, using different vaccination strategies compared with the cNIP in Argentina. METHODS: A published dynamic transmission model adapted for Argentina evaluated six vaccination strategies versus the cNIP: infant 4CMenB alone (1), infant 4CMenB with adolescent MenACWY (2), adolescent MenACWY alone (3), infant 4CMenB & MenACWY (4), infant MenACWY alone (5), and infant 4CMenB & MenACWY with adolescent MenACWY (6). RESULTS: Strategies including adolescent MenACWY with infant 4CMenB (or 4CMenB plus MenACWY) vaccination had the largest impact on increasing IMD prevention i.e., up to 23 % higher than the cNIP after 25 years. Strategies including 4CMenB (1, 2, 4, 6) had the largest reduction of serogroup B IMD (impact is seen among children 0-4 years old) i.e., a 39 % decrease within the first five years of introducing 4CMenB. Strategies including adolescent MenACWY (cNIP, 2, 3 and 6) had the largest reduction of serogroup ACWY IMD, with near elimination after 30 years (impact seen in all ages, due to herd protection). CONCLUSIONS: Adding routine infant 4CMenB (either to the complete cNIP or instead of infant MenACWY) could further reduce IMD cases, sequelae, and deaths in Argentina. In addition, maintaining the adolescent MenACWY program, with its herd immunity benefits, could achieve near elimination of serogroup ACWY IMD over 30 years.
引用
- Gómez JA, Pannunzio ME, Karwala P, et al. Impact on meningococcal disease of different vaccination strategies with 4CMenB and MenACWY-CRM197 in infants and adolescents in Argentina. Vaccine. 2024. PMID: 39719770. doi:10.1016/j.vaccine.2024.126589
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。